Intech Investment Management LLC Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Intech Investment Management LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 224,853 shares of the healthcare conglomerate’s stock after selling 15,470 shares during the quarter. UnitedHealth Group accounts for approximately 1.7% of Intech Investment Management LLC’s portfolio, making the stock its 6th largest holding. Intech Investment Management LLC’s holdings in UnitedHealth Group were worth $118,378,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in UNH. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $26,000. CGC Financial Services LLC raised its stake in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the period. LFA Lugano Financial Advisors SA grew its stake in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares during the period. O Brien Wealth Partners LLC lifted its holdings in UnitedHealth Group by 36.8% during the fourth quarter. O Brien Wealth Partners LLC now owns 78 shares of the healthcare conglomerate’s stock valued at $41,000 after purchasing an additional 21 shares during the last quarter. Finally, Friedenthal Financial purchased a new position in shares of UnitedHealth Group in the fourth quarter worth about $42,000. 87.86% of the stock is owned by institutional investors.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available through this link. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Trading Down 1.7 %

UnitedHealth Group stock traded down $8.66 during mid-day trading on Friday, hitting $508.17. The company’s stock had a trading volume of 2,528,228 shares, compared to its average volume of 2,805,318. The stock has a market cap of $467.71 billion, a price-to-earnings ratio of 31.06, a price-to-earnings-growth ratio of 1.47 and a beta of 0.55. The business has a 50 day moving average price of $489.23 and a 200-day moving average price of $510.73. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the firm earned $6.26 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

Analyst Ratings Changes

A number of research firms recently weighed in on UNH. TD Cowen reduced their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Stephens reiterated an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Piper Sandler raised their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Finally, Truist Financial reiterated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Three investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.